373 related articles for article (PubMed ID: 8136018)
1. Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.
Whinna HC; Church FC
J Protein Chem; 1993 Dec; 12(6):677-88. PubMed ID: 8136018
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of dysthrombins Quick I and II by heparin cofactor II and antithrombin.
Phillips JE; Shirk RA; Whinna HC; Henriksen RA; Church FC
J Biol Chem; 1993 Feb; 268(5):3321-7. PubMed ID: 8429008
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of a thrombin anion-binding exosite-2 mutant by the glycosaminoglycan-dependent serpins protein C inhibitor and heparin cofactor II.
Cooper ST; Rezaie AR; Esmon CT; Church FC
Thromb Res; 2002 Jul; 107(1-2):67-73. PubMed ID: 12413592
[TBL] [Abstract][Full Text] [Related]
4. RNA aptamer to thrombin binds anion-binding exosite-2 and alters protease inhibition by heparin-binding serpins.
Jeter ML; Ly LV; Fortenberry YM; Whinna HC; White RR; Rusconi CP; Sullenger BA; Church FC
FEBS Lett; 2004 Jun; 568(1-3):10-4. PubMed ID: 15196911
[TBL] [Abstract][Full Text] [Related]
5. Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II.
Becker DL; Fredenburgh JC; Stafford AR; Weitz JI
J Biol Chem; 1999 Mar; 274(10):6226-33. PubMed ID: 10037709
[TBL] [Abstract][Full Text] [Related]
6. Role of thrombin exosites in inhibition by heparin cofactor II.
Rogers SJ; Pratt CW; Whinna HC; Church FC
J Biol Chem; 1992 Feb; 267(6):3613-7. PubMed ID: 1740413
[TBL] [Abstract][Full Text] [Related]
7. Serpin-glycosaminoglycan interactions.
Rein CM; Desai UR; Church FC
Methods Enzymol; 2011; 501():105-37. PubMed ID: 22078533
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex.
Li W; Adams TE; Nangalia J; Esmon CT; Huntington JA
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4661-6. PubMed ID: 18362344
[TBL] [Abstract][Full Text] [Related]
9. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans.
Sheehan JP; Tollefsen DM; Sadler JE
J Biol Chem; 1994 Dec; 269(52):32747-51. PubMed ID: 7806495
[TBL] [Abstract][Full Text] [Related]
10. General features of the heparin-binding serpins antithrombin, heparin cofactor II and protein C inhibitor.
Pratt CW; Church FC
Blood Coagul Fibrinolysis; 1993 Jun; 4(3):479-90. PubMed ID: 8392392
[TBL] [Abstract][Full Text] [Related]
11. Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity.
Sheehan JP; Wu Q; Tollefsen DM; Sadler JE
J Biol Chem; 1993 Feb; 268(5):3639-45. PubMed ID: 8429040
[TBL] [Abstract][Full Text] [Related]
12. Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes.
Myles T; Church FC; Whinna HC; Monard D; Stone SR
J Biol Chem; 1998 Nov; 273(47):31203-8. PubMed ID: 9813026
[TBL] [Abstract][Full Text] [Related]
13. Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor.
Neese LL; Wolfe CA; Church FC
Arch Biochem Biophys; 1998 Jul; 355(1):101-8. PubMed ID: 9647672
[TBL] [Abstract][Full Text] [Related]
14. Essential thrombin residues for inhibition by protein C inhibitor with the cofactors heparin and thrombomodulin.
Fortenberry YM; Whinna HC; Cooper ST; Myles T; Leung LL; Church FC
J Thromb Haemost; 2007 Jul; 5(7):1486-92. PubMed ID: 17635698
[TBL] [Abstract][Full Text] [Related]
15. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
16. Mutagenesis of recombinant protein C inhibitor reactive site residues alters target proteinase specificity.
Phillips JE; Cooper ST; Potter EE; Church FC
J Biol Chem; 1994 Jun; 269(24):16696-700. PubMed ID: 8206990
[TBL] [Abstract][Full Text] [Related]
17. Role of Leu99 of thrombin in determining the P2 specificity of serpins.
Rezaie AR
Biochemistry; 1997 Jun; 36(24):7437-46. PubMed ID: 9200692
[TBL] [Abstract][Full Text] [Related]
18. Modulation of protein C inhibitor activity.
Neese LL; Pratt CW; Church FC
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):737-46. PubMed ID: 7532447
[TBL] [Abstract][Full Text] [Related]
19. Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin.
Chuang YJ; Swanson R; Raja SM; Olson ST
J Biol Chem; 2001 May; 276(18):14961-71. PubMed ID: 11278930
[TBL] [Abstract][Full Text] [Related]
20. Allosteric changes in thrombin's activity produced by peptides corresponding to segments of natural inhibitors and substrates.
Hortin GL; Trimpe BL
J Biol Chem; 1991 Apr; 266(11):6866-71. PubMed ID: 1849894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
